THE FUTURE OF
EYE CARE
Rose Bengal & Photodynamic Therapy
Revolutionary Treatments for Infectious Keratitis and Other Eye Diseases
About VisiRose, Inc.
Vision is humanity’s most treasured sense.
Yet for countless people worldwide, the scourge of eye infection and disease has stolen this precious faculty of sight, cloaking them in shadows, discomfort, and often perpetual darkness.
VisiRose is pioneering a global revolution to protect and restore vision. Through invention, science, and technology, VisiRose is committed to reclaiming what has been lost, offering the transformative gift of renewed sight.
VisiRose is a startup biotechnology company of the University of Miami and Provectus Biopharmaceuticals, focused on commercializing the Miller School of Medicine’s Bascom Palmer Eye Institute and its Ophthalmic Biophysics Center’s innovative ocular research using bioactive synthetic small molecule rose bengal.
VisiRose is transforming lives through the restoration of vision.
Innovation and Clinical Validation at the Core of VisiRose, Inc.
U.S. #1 in Ophthalmology
for 20+ years
Translational
Vision
Research Center
Pharmaceutical-Grade Rose Bengal
API
Management Team
Ed Pershing, CPA
Chairman of the Board
CEO and Chairman of Provectus Biopharmaceuticals; Previously CEO and co-founder of Pershing Yoakley & Associates (PYA), a top 20 healthcare consulting and top 100 accounting firm in the U.S.
Other healthcare-focused companies: Healthcare Horizons Consulting Group, Realty Trust Group, PYA Waltman Capital, PYA Data Analytics
Community-Based Not-For-Profit Organizations: Knoxville Area Project Access (KAPA), Maternity Center of East Tennessee, Tennessee Health Partnership (THP)
Dominic Rodrigues
Acting Chief Executive Officer; Director
President and Vice Chairman of Provectus; Previously worked in management consulting and corporate development in science and technology-driven industries
Finance professor at the University of Nevada, Las Vegas; Venture capitalist at defense contractor SAIC; Currency derivatives trader at Bank of Montreal; Project manager and engineer at Jacques Whitford
Heather Raines, CPA
Acting Chief Financial Officer
CFO of Provectus; Previously VP of Finance for BDry Waterproofing and AMT Business Unit Controller at AMETEK (NYSE: AME)
Tax analyst at Goody’s Family Clothing; Accounting Manager at Siemens Medical Solutions USA, a wholly owned subsidiary of Siemens AG (NYSE: SI), and CTI Molecular Imaging (Nasdaq: CTMI)
John Lacey, III, M.D
Director
Former Chief Medical Officer and Senior Vice President of University Health System d/b/a University of Tennessee Medical Center (UTMC)
Internal medicine practitioner for 39 years
Helped create KAPA
Webster Bailey
Director
Executive Director of Metro Drug Coalition
Previously 15-year career working in a residential addiction treatment center setting
Winner of multiple awards and accolades for substance abuse prevention initiatives
Receive News & Updates
Thank you for subscribing!
Have a great day!